[1] DENIZ TUMEN,PHILIPP HEUMANN,KARSTEN GULOW,et al.Pathogenesis and current treatment strategies of hepatocellular carcinoma[J].Biomedicines,2022,10(12):3202.
[2] YANG YQ,WEN ZY,LIU XY,et al.Current status and prospect of treatments for recurrent hepatocellular carcinoma[J].World J Hepatol,2023,15(2):129-150.
[3] JAMES YU,ROBIN PARK,RICHARD KIM.Promising novel biomarkers for hepatocellular carcinoma:diagnostic and prognostic insights[J].Hepatocell Carcinoma,2023,10:1105-1127.
[4]AYUSH RANAWADE,RATI SHARMA,EREL LEVINE.Lessons learned from two decades of modeling the heat-shock response[J].Biomolecules,2022,12(11):1645.
[5] FAN Y,MENG Z,ZHANG C,et al.DNAJ heat shock protein family member C1 can regulate proliferation and migration in hepatocellular carcinoma[J].PeerJ,2023,11:e15700.
[6]ZHANG Kailin,PAN Hongxu,ZHAO Yuwen,et al.Genetic analysis of HSP40/DNAJ family genes in Parkinson's disease:a large case-control study[J].Molecular Neurobiology,2022,59(9):5443-5451.
[7] IMAMURA T,KOMATSU S,ICHIKAWA D,et al.Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma[J].Carcinogenesis,2018,39:263-271.
[8] DEMAJO S,URIBESALGO I,GUTIERREZ A,et al.ZRF1 controls the retinoic acid pathway and regulates leukemogenic potential in acute myeloid leukemia[J].Oncogene,2014,33:5501-5510.
[9] XU Junxiu,ZHANG Kai,ZHANG Genhao,et al.Prognostic lysosome-related biomarkers for predicting drug candidates in hepatocellular carcinoma:an insilco analysis[J].Journal of Hepatocellular Carcinoma,2023,10:459-472.
[10] CHANDRASHEKAR DS,KARTHIKEYAN SK,KORLA PK,et al.UALCAN:An update to the integrated cancer data analysis platform[J].Neoplasia,2022,25:18-27.
[11] LIU Xiaowei,XU Haowei,YI Yuyang,et al.Role of ferroptosis and immune infiltration in intervertebral disc degeneration:novel insights from bioinformatics analyses[J].Frontiers in Cell and Developmental Biology,2023,11:1170758.
[12] BADARNI M,GABBAY S,ELKABETS M,et al.Gene expression and drug sensitivity analysis of mitochondrial chaperones reveals that HSPD1 and TRAP1 expression correlates with sensitivity to inhibitors of DNA replication and mitosis[J].Biology (Basel),2023,12(7):988.
[13] JIA Yachun,LIU Rui,SHI Luyi,et al.Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma[J].BMC Cancer,2023,23(1):859.
[14]LIU Manru,SHI Ce,SONG Qiuya,et al.Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma[J].Hepatology Communications,2023,7(10):e0246.
[15] KONG Yun,GUO Li.Sunitinib suppresses M2 polarization of macrophages in tumor microenvironment to regulate hepatocellular carcinoma progression[J].Journal of Biochemical and Molecular Toxicology,2023,37(6):e23333.
[16] PAN Xuwang,HUANG Jinsong,LIU Shourong,et al.pH-responsive and liver-targeting drug delivery system for combination delivery of artesunate with arsenic trioxide prodrug against hepatocellular carcinoma[J].Drug Development and Industrial Pharmacy,2023,49(8):485-496.